Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
PR Newswire

Unite Calls for Government Decision to Save Jobs and Skills on GBP13bn NHS IT Contract

— LONDON, June 16

LONDON, June 16 /PRNewswire/ -- Unite, the UK's largest union, is today, in advance of a Parliamentary Inquiry, calling for the Government to act to safeguard the jobs and skills of up to 1,000 people working on the GBP12.7bn NHS IT contract for the IT services company Fujitsu.

This follows the decisions of Fujitsu to withdraw from contract negotiations and termination of the GBP1.1bn contract share for the south of England announced two weeks ago.

There are currently nearly 1,000 people in Fujitsu working on the NHS IT contract and related activities to modernise IT systems, provide electronic patient records and quick and easy access to information and test results.

NHS Chief Executive David Nicholson and Chief Operating Officer Gordon Hextall are due to appear before the House of Commons Public Accounts Committee on Monday 16th June to provide a progress update on the computerisation contract, the largest ever civilian IT contract.

Peter Skyte, Unite National Officer, said: "We want the Public Accounts Committee at its hearing on Monday to press the Government to make a quick decision to end the present uncertainty and insecurity for the highly skilled IT people working on the NHS contract for Fujitsu.

"Government must act to ensure that the knowledge and skills gained in working for Fujitsu are retained, whoever the provider or providers in the future, and ensure that the skilled staff can help the project continue to a successful conclusion in the interests of patients, the NHS and the health of the nation."

Related news

Partnering consultation free of charge
Bioiberica
Molecular Diagnostics Conference
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us